{
  "meta": {
    "title": "Gsds_Glycogen_Storage_Diseases",
    "url": "https://brainandscalpel.vercel.app/gsds-glycogen-storage-diseases-40ce0e5c.html",
    "scrapedAt": "2025-11-29T18:23:10.713Z"
  },
  "questions": [
    {
      "id": 6396,
      "choices": [
        {
          "id": 25553,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle phosphorylase </span></span></span></p>"
        },
        {
          "id": 25554,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver phosphorylase kinase</span></span></span></p>"
        },
        {
          "id": 25555,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose 6 phosphatase</span></span></span></p>"
        },
        {
          "id": 25556,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branching enzyme</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male presents with complaints of pain in his calves during and after physical activity. Upon further evaluation, including a detailed examination and muscle biopsy, it was noted that there was an increased glycogen accumulation in the muscle tissues. Based on these findings, which of the following enzymes is most likely deficient in this patient?</span></span></span><br />\r\n&nbsp;</p>",
      "unique_key": "Q3908211",
      "question_audio": null,
      "question_video": null,
      "map_id": 29994,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Muscle phosphorylase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical case scenario is a<strong> Glycogen storage disorder, Type V &ndash; McArdle&rsquo;s syndrome </strong>caused by <strong>defective muscle Glycogen</strong> <strong>Phosphorylase </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp; Liver phosphorylase kinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is a <strong>type VIII</strong> disorder with <strong>hepatomegaly,</strong> accumulation of <strong>glycogen in liver</strong> and mild <strong>hypoglycaemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glucose 6 phosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is <strong>deficient</strong> in <strong>Von Gierke disease (Ia),&nbsp;</strong>C/F includes<strong> glycogen</strong> accumulation in <strong>liver and renal</strong> <strong>tubule cells, hypoglycaemia, lactic academia, ketosis and hyperlipemia.</strong>(No muscle weakness).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp; Branching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is defective in<strong> Andersen disease</strong> with <strong>Hepatosplenomegaly</strong>; accumulation of <strong>polysaccharide </strong>with<strong> few</strong> <strong>branch points</strong>; <strong>death</strong> from<strong> heart or liver failure before age 5.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture14.jpg\" style=\"height:503px; width:1000px\" /><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture15.jpg\" style=\"height:420px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: P 179.</span></strong></span></span></p>",
      "correct_choice_id": 25553,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6372,
      "choices": [
        {
          "id": 25457,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branching enzyme&nbsp;&nbsp; </span></span></span></p>"
        },
        {
          "id": 25458,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Debranching enzyme&nbsp;&nbsp; </span></span></span></p>"
        },
        {
          "id": 25459,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle phosphorylase</span></span></span></p>"
        },
        {
          "id": 25460,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphatase </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old male with a history of short stature presents to the clinic with recurrent episodes of hypoglycemia, hepatomegaly, and bleeding tendencies. On examination, the patient also has notable hepatomegaly and enlarged kidneys. Laboratory findings include elevated levels of lactate, cholesterol, triglycerides, and uric acid. Considering the constellation of symptoms and lab findings, which enzyme deficiency is most likely responsible for this patient&#39;s clinical presentation?</span></span></span></p>",
      "unique_key": "Q2047612",
      "question_audio": null,
      "question_video": null,
      "map_id": 29988,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Glucose-6-phosphatase&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient is having classic<strong> signs and symptoms of Von Gierke disease.</strong> It is due to<strong> deficiency </strong>of the enzyme<strong> glucose-6-phosphatase.</strong> This disease usually manifests in the first 12 months of life.&nbsp; </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lab results reveal <strong>increased lactate, cholesterol, triglyceride and uric acid levels</strong>.&nbsp; This condition is caused by a<strong> basic</strong> <strong>enzyme.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; Branching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> deficiency results in <strong>Anderson disease</strong>. C/F: <strong>failure to thrive, liver failure, and hypotonia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp; Debranching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> deficiency results in<strong> Cori disease</strong>. C/F: <strong>hypoglycemia, hepatomegaly, short-stature, and myopathy.&nbsp; </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Muscle phosphorylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> deficiency results in <strong>McArdle disease.</strong> C/F: <strong>pain, cramps and myoglobinuria on strenuous exercise.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Von Gierke&#39;s disease (Type I glycogen storage disease)</strong>, characterized by a<strong> deficiency in glucose-6-phosphatase. </strong>This enzyme is crucial for the <strong>final steps of gluconeogenesis and glycogenolysis,</strong> converting<strong> glucose-6-phosphate</strong> into <strong>free glucose</strong>. Its<strong> deficiency</strong> leads to <strong>impaired glucose production</strong>, resulting in <strong>hypoglycemia, </strong>and the accumulation of<strong> glycogen and fat </strong>in the<strong> liver and kidneys,</strong> causing <strong>hepatomegaly and renal enlargement</strong>. The <strong>increased </strong>levels of <strong>lactate, cholesterol, triglycerides,</strong> and<strong> uric acid </strong>are also consistent with the<strong> metabolic disturbances </strong>seen in <strong>von Gierke&#39;s disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 179,355</span></strong></span></span></p>",
      "correct_choice_id": 25460,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6367,
      "choices": [
        {
          "id": 25437,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Debranching enzyme</span></span></span></p>"
        },
        {
          "id": 25438,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle phosphorylase</span></span></span></p>"
        },
        {
          "id": 25439,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphatase</span></span></span></p>"
        },
        {
          "id": 25440,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branching enzyme</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a pediatric grand rounds presentation, a challenging case involving a 6-month-old infant with recurrent episodes of early morning hypoglycemia is discussed. The attending physician explains that administering glucagon raised the infant&#39;s blood glucose levels when fed but was ineffective during fasting periods. A liver biopsy revealed abnormal glycogen accumulation. The audience, consisting of pediatricians JRs, is then asked to determine the enzyme deficiency responsible for the infant&#39;s condition based on the clinical findings?</span></span></span></p>",
      "unique_key": "Q9145065",
      "question_audio": null,
      "question_video": null,
      "map_id": 29995,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp; Debranching enzyme</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most probable diagnosis is<strong> Glycogen storage diseases</strong>: <strong>Cori&rsquo;s / Limit dextrinosis, Forbes disease (Type IIIa)</strong> - deficient <strong>liver and muscle</strong> <strong>debranching enzyme.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical presentation includes<strong> fasting hypoglycaemia, hepatomegaly, accumulation of branched polysaccharide (limit dextrin) &amp; muscle weakness. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In<strong> fed state</strong>, <strong>glycogen</strong> is present. So, <strong>glucagon stimulates </strong>enzyme <strong>phosphorylase</strong> to <strong>cleave glycogen</strong> there by releasing <strong>glucose to circulation.</strong> I<strong>n fasting state</strong>, there is only <strong>limit dextrin</strong> and <strong>no</strong> effect of <strong>glucagon on debranching enzyme</strong>. Hence, the<strong> glucagon </strong>will<strong> not</strong> <strong>raise</strong> the<strong> blood glucose levels. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Muscle phosphorylase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Type V &ndash; McArdle&rsquo;s syndrome; Poor exercise tolerance</strong> with <strong>high muscle glycogen </strong>and<strong> low blood</strong> <strong>lactate</strong> after exercise.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glucose-6-phosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is <strong>deficient in Von Gierke disease (Ia)</strong>,C/F includes<strong> glycogen accumulation in liver </strong>and <strong>renal</strong> t<strong>ubule cells</strong>, <strong>hypoglycaemia, lactic academia</strong>, <strong>ketosis and hyperlipidemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Branching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is<strong> defective in Anderson disease </strong>with <strong>Hepatosplenomegaly;</strong> accumulation of<strong> polysaccharide</strong> with <strong>few</strong> <strong>branch</strong> points; <strong>death from heart or liver failure </strong>before<strong> age 5.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical features of <strong>Type III Glycogen Storage Disease (Cori&#39;s or Forbes&#39; Disease)</strong> caused by a <strong>deficiency </strong>in the <strong>debranching</strong> enzyme, leading to <strong>impaired glycogenolysis</strong>,<strong> glycogen accumulation </strong>in the<strong> liver, and fasting hypoglycemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 179.</span></strong></span></span></p>",
      "correct_choice_id": 25437,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6369,
      "choices": [
        {
          "id": 25445,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle debranching enzyme </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\"> </span></span></span></span></p>"
        },
        {
          "id": 25446,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle phosphorylase </span></span></span></p>"
        },
        {
          "id": 25447,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose 6 phosphatase</span></span></span></p>"
        },
        {
          "id": 25448,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branching enzyme</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male visits his primary care physician complaining of recurrent episodes of pain in his calves triggered by physical activity. He reports no other symptoms or significant medical history. Given the concern for a metabolic muscle disorder, a muscle biopsy is performed, revealing an accumulation of glycogen within the muscle cells. Based on the patient&#39;s symptoms and biopsy findings, which enzyme deficiency is most likely responsible for his condition?</span></span></span><br />\r\n&nbsp;</p>",
      "unique_key": "Q2735829",
      "question_audio": null,
      "question_video": null,
      "map_id": 29986,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Muscle Phosphorylase </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation is indicative of<strong> McArdle&#39;s disease (Type V glycogen storage disease)</strong>, characterized by a <strong>deficiency</strong> in <strong>muscle phosphorylase</strong>. This enzyme is crucial for<strong> glycogenolysis in muscle tissue, </strong>and <strong>its deficiency</strong> leads to an<strong> inability to break</strong> <strong>down glycogen</strong> into<strong> glucose during exercise, </strong>resulting in <strong>muscle pain and cramping</strong>. The<strong> accumulation of glycogen </strong>in <strong>muscle biopsy</strong> further supports this diagnosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Muscle debranching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Deficiency </strong>in the muscle debranching enzyme leads to <strong>Cori&#39;s disease (Type III glycogen</strong> <strong>storage disease)</strong>, which typically presents with more systemic symptoms, including<strong> hepatomegaly, </strong>in addition to<strong> muscle weakness.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glucose 6 phosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Deficiency</strong> of <strong>glucose-6-phosphatase </strong>characterizes <strong>von Gierke&#39;s disease (Type I glycogen storage</strong> <strong>disease</strong>), primarily affecting<strong> liver function</strong> and leading to <strong>hypoglycemia, not isolated muscle symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Branching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>deficiency</strong> in the branching enzyme results in <strong>Andersen&#39;s disease </strong>(<strong>Type IV glycogen storage disease</strong>), which is associated with<strong> liver dysfunction and progressive cirrhosis</strong>, rather than <strong>isolated muscle symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture12.jpg\" style=\"height:873px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 179.</span></strong></span></span></p>",
      "correct_choice_id": 25446,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6374,
      "choices": [
        {
          "id": 25465,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased availability of glucose to tissues </span></span></span></p>"
        },
        {
          "id": 25466,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More formation of pentoses</span></span></span></p>"
        },
        {
          "id": 25467,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased accumulation of sorbitol</span></span></span></p>"
        },
        {
          "id": 25468,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Impaired degradation of free radicals</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old child presents to the pediatric clinic with recurrent episodes of hypoglycemia, especially noted during fasting periods. The child&#39;s growth parameters are below the normal percentile for age. Laboratory investigations reveal lactic acidosis and hyperuricemia. After further evaluation, the child is diagnosed with Glucose-6-phosphatase deficiency. The attending physician explains to the parents the association between the child&#39;s condition and the development of hyperuricemia and gout. Which of the following is the most likely cause of hyperuricemia and gout in this patient?</span></span></span></p>",
      "unique_key": "Q6724837",
      "question_audio": null,
      "question_video": null,
      "map_id": 29989,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) More formation of pentoses</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose-6-phosphatase deficiency</strong>, also known as<strong> Glycogen Storage Disease Type I (GSD I)</strong>, leads to an<strong> inability</strong> to convert <strong>glucose</strong>-<strong>6-phosphate into glucose, </strong>resulting in the <strong>trapping of glucose</strong> within <strong>cells </strong>and subsequent<strong> hypoglycemia.</strong> To compensate for the <strong>lack</strong> of available<strong> glucose,</strong> the body <strong>increases </strong>the breakdown of <strong>nucleic acids to produce more glucose </strong>through <strong>gluconeogenesis,</strong> leading to an <strong>excess</strong> production of <strong>purine bases. </strong>The <strong>increased </strong>turnover of these <strong>purine bases</strong> ultimately results in the<strong> overproduction </strong>of <strong>uric acid, </strong>a precursor to<strong> gout</strong>. This pathway also leads to an <strong>increased formation of pentoses</strong>, which are involved in the <strong>synthesis of</strong> <strong>nucleic acids,</strong> thus contributing to the<strong> cycle of purine breakdown </strong>and<strong> uric acid production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Decreased availability of glucose to tissues: This</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a direct consequence of <strong>Glucose-6-phosphatase deficiency</strong> leading to <strong>hypoglycemia</strong> but <strong>does not </strong>directly cause<strong> hyperuricemia and gout</strong>. The <strong>lack of glucose</strong> exacerbates the<strong> metabolic imbalance</strong> but <strong>isn&#39;t </strong>the primary cause of<strong> increased uric acid levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Increased accumulation of sorbitol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Sorbitol accumulation is associated with conditions like <strong>diabetes mellitus </strong>due to <strong>increased</strong> activity of the <strong>polyol pathway</strong> when<strong> glucose levels are high.</strong> It is<strong> not </strong>directly related to <strong>Glucose-6-phosphatase deficiency</strong> or<strong> hyperuricemia and gout</strong> in this context.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Impaired degradation of free radicals:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>oxidative stress </strong>and <strong>impaired degradation of free radicals </strong>can contribute to <strong>cellular damage</strong> and various <strong>metabolic disturbances</strong>, they are<strong> not directly </strong>involved in the mechanism leading to<strong> hyperuricemia </strong>and <strong>gout </strong>in patients with<strong> Glucose-6-phosphatase deficiency.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biochemical defect in von Gierke&rsquo;s disease:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficiency of Glucose 6 Phosphatase</strong>&nbsp; &rarr; accumulation of<strong> Glucose 6 Phosphate</strong> &rarr; it is&nbsp; channelled to <strong>Pentose Phosphate pathway </strong>&rarr; <strong>more Pentoses</strong> are formed &rarr; enters <strong>Purine Synthesis </strong>&rarr; <strong>Uric acid</strong> accumulates (<strong>degradation product of Purine</strong>)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Nelson 20/e: Defects in the metabolism of Carbohydrates</span></strong></span></span></p>",
      "correct_choice_id": 25466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6390,
      "choices": [
        {
          "id": 25529,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branching enzyme</span></span></span></p>"
        },
        {
          "id": 25530,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acid maltase</span></span></span></p>"
        },
        {
          "id": 25531,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle phosphorylase</span></span></span></p>"
        },
        {
          "id": 25532,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphatase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-month-old infant is presented to the pediatric outpatient department by the mother, reporting symptoms of rapid heart rate, restlessness, muscle hypotonia, and abdominal distention. The infant has been diagnosed with cardiac failure and is currently being treated with diuretics and an ACE inhibitor. Radiographic evidence indicates left ventricular hypertrophy, and physical examination reveals hepatosplenomegaly. An assay performed on a dried blood spot indicates reduced activity of a specific enzyme, leading to a diagnosis of Pompe disease. Which enzyme deficiency is associated with Pompe disease?</span></span></span><br />\r\n&nbsp;</p>",
      "unique_key": "Q8718574",
      "question_audio": null,
      "question_video": null,
      "map_id": 29992,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Acid maltase&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pompe disease,</strong> also known as<strong> Glycogen Storage Disease Type II,</strong> is caused by a<strong> deficiency </strong>in the enzyme <strong>acid alpha-glucosidase,</strong> also known as<strong> acid maltase</strong>. This<strong> lysosomal</strong> enzyme is responsible for <strong>breaking down glycogen </strong>into <strong>glucose</strong> <strong>within lysosomes.</strong> Its <strong>deficiency</strong> leads to the <strong>accumulation of lysosomal glycogen</strong>, particularly affecting <strong>cardiac and skeletal muscles</strong>, as well as the<strong> liver.</strong> The <strong>hallmark </strong>features of<strong> Pompe disease</strong> include <strong>cardiomyopathy</strong> (often presenting as<strong> cardiac failure in infants</strong>), <strong>muscle weakness</strong> (hypotonia), and <strong>hepatomegaly</strong>. The <strong>diagnosis</strong> is supported by<strong> enzyme </strong>assays showing<strong> reduced acid maltase activity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; Branching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> deficiency results in <strong>Anderson disease</strong>. C/F: failure to<strong> thrive, liver failure, and hypotonia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Muscle phosphorylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> deficiency results in<strong> McArdle disease.</strong> C/F: <strong>pain, cramps and myoglobinuria on strenuous exercise.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Glucose-6-phosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Deficiency results in <strong>Von Gierke disease</strong>. C/F: <strong>Hypoglycaemia; hyperketonaemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture6.jpg\" style=\"height:598px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture7.jpg\" style=\"height:332px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 179.</span></strong></span></span></p>",
      "correct_choice_id": 25530,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6386,
      "choices": [
        {
          "id": 25513,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branching enzyme</span></span></span></p>"
        },
        {
          "id": 25514,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Debranching enzyme</span></span></span></p>"
        },
        {
          "id": 25515,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle phosphorylase</span></span></span></p>"
        },
        {
          "id": 25516,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphatase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old girl child is admitted with progressive abdominal distension for the past 6 months. Mother reported that the baby has difficulty in walking, gets easily tired while playing and restless and sweat in early morning hours. After giving juice or milk, she feels comfortable.&nbsp;On examination, child was found to have motor retardation and was small for age. Liver was found to be enlarged with firm consistency. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laboratory investigations:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FBS: 60 mg/dl (normal = 80-110 mg/dl)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">AST: 355 IU/L (normal = 15-45 IU/L)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ALT: 244 IU/L (normal = 15-45 IU/L)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ALP: 231 IU/L (normal =98-279 IU/L)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total bilirubin: 2.0 mg/dl (normal = 0-1.0 mg/dl)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver histology: Glycogen laden vacuoles with no fibrosis or inflammatory cell infiltration. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture4.jpg\" style=\"height:247px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Baby was diagnosed with GSD type III based on the results.&nbsp; What is the causative enzyme deficiency in this disease?</span></span></span></p>",
      "unique_key": "Q8585097",
      "question_audio": null,
      "question_video": null,
      "map_id": 29991,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Debranching enzyme&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogen Storage Disease (GSD) Type III,</strong> also known as<strong> Cori disease or Forbes disease, </strong>is caused by a <strong>deficiency </strong>in the <strong>debranching enzyme </strong>(<strong>amylo-1,6-glucosidase, 4-alpha-glucanotransferase</strong>). This enzyme is crucial for the <strong>breakdown of glycogen</strong>, specifically in removing <strong>branch points</strong> in glycogen. A deficiency in this enzyme leads to the <strong>accumulation of abnormal glycogen</strong> with short outer branches, which is evident in the <strong>liver histology </strong>of the patient as <strong>glycogen-laden vacuoles.</strong> This <strong>accumulation disrupts</strong> normal <strong>glycogenolysis and gluconeogenesis</strong>, leading to symptoms such as<strong> hypoglycemia, hepatomegaly, and growth retardation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Branching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>deficiency</strong> results in <strong>Anderson disease</strong>. C/F: <strong>failure to thrive, liver failure, and hypotonia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp; Muscle phosphorylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>deficiency</strong> results in <strong>McArdle disease.</strong> C/F: <strong>pain, cramps and myoglobinuria</strong> on strenuous exercise.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Glucose-6-phosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Deficiency </strong>results in <strong>Von Gierke disease.</strong> C/F: <strong>Hypoglycemia; hyperketonaemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture10.jpg\" style=\"height:560px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture11_PgLn01X.jpg\" style=\"height:469px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 179.</span></strong></span></span></p>",
      "correct_choice_id": 25514,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6454,
      "choices": [
        {
          "id": 25785,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the fasting plasma sugar is more than 126 mg /dl, on more than one occasion</span></span></span></p>"
        },
        {
          "id": 25786,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If 2-hr post-glucose load value of GTT is more than 200 mg /dl (even at one occasion).</span></span></span></p>"
        },
        {
          "id": 25787,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the random plasma sugar level is more than 200 mg/dl, on more than one occasion. </span></span></span></p>"
        },
        {
          "id": 25788,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the above</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following options correctly represents the diagnostic criteria for Diabetes Mellitus?</span></span></p>",
      "unique_key": "Q5443220",
      "question_audio": null,
      "question_video": null,
      "map_id": 29993,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All the above</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnostic<strong> criteria for Diabetes Mellitus</strong> include several key measurements, each of which can independently confirm the diagnosis:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fasting Plasma Glucose (FPG)</strong>: A value of <strong>126 mg/dl (7.0 mmol/l) or higher,</strong> <strong>confirmed </strong>on <strong>more than one occasion, </strong>indicates diabetes.<strong> Fasting </strong>is defined as<strong> no caloric intake for at least 8 hours.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2-hour Plasma Glucose During an Oral Glucose Tolerance Test (OGTT)</strong>: A value of<strong> 200 mg/dl (11.1 mmol/l) or higher at the 2-hour</strong> mark during an<strong> OGTT,</strong> using a <strong>glucose load of 75 grams,</strong> confirms the diagnosis. This criterion <strong>does not </strong>necessarily require <strong>confirmation </strong>on a <strong>second occasion</strong> if the patient presents with<strong> classic symptoms of hyperglycemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Random Plasma Glucose</strong>: A value of<strong> 200 mg/dl (11.1 mmol/l) or higher, </strong>in a patient with <strong>classic symptoms of hyperglycemia</strong> (e.g., <strong>polyuria, polydipsia, unexplained weight loss</strong>), can <strong>confirm the diagnosis </strong>of<strong> diabetes</strong> without the need for fasting or an OGTT.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given that each of these criteria can independently diagnose Diabetes Mellitus, <strong>option D) All the above is correct.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<u>Explanation:</u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fasting plasma sugar more than 126 mg/dl, on more than one occasion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is one of the criteria for diagnosing diabetes but not the only one.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp; 2-hour post-glucose load value of GTT more than 200 mg/dl: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This too is a valid criterion for diagnosing diabetes, even if observed on just one occasion, provided there are classic symptoms of hyperglycemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Random plasma sugar level more than 200 mg/dl, on more than one occasion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While a single measurement with classic symptoms can be sufficient, additional confirmation enhances the diagnostic certainty, especially in asymptomatic individuals.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the <strong>fasting plasma sugar</strong> is <strong>more than 126 mg /dl, </strong>on <strong>more</strong> than one occasion</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If<strong> 2-hr post-glucose </strong>load value of<strong> GTT is more than 200 mg /dl</strong> (even at one occasion).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the<strong> random plasma sugar level </strong>is <strong>more than 200 mg/dl</strong>, on<strong> more than one occasion. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycated haemoglobin (Glyco -Hb) </strong>or<strong> HbA1c </strong>level <strong>more than 6.5%</strong> at<strong> any occasion </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture5_cgQTuPi.jpg\" style=\"height:201px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: 314.</span></strong></span></span></p>",
      "correct_choice_id": 25788,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9571,
      "choices": [
        {
          "id": 38251,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">They are often associated with deficient enzyme activity.</span></span></span></p>"
        },
        {
          "id": 38252,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Both alleles contain the same mutation.</span></span></span></p>"
        },
        {
          "id": 38253,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">They are more variable than autosomal dominant conditions.</span></span></span></p>"
        },
        {
          "id": 38254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Most persons do not carry any abnormal recessive genes.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the context of type IV glycogen storage disease (GSD IV), an autosomal recessive condition characterized by progressive liver damage, hypoglycemia, hyperlipidemia, and hyperuricemia due to deficient glycogenolysis, which of the following statements accurately describes autosomal recessive conditions?</span></span></span></p>",
      "unique_key": "Q2685119",
      "question_audio": null,
      "question_video": null,
      "map_id": 29987,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. They are often associated with deficient enzyme activity.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Autosomal</strong> and <strong>X-linked recessive inheritance</strong> is seen in almost all <strong>metabolic diseases</strong> as seen in <strong>type IV glycogen storage disease. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Traits</strong> such as <strong>deafness </strong>can <strong>follow any of the three major mendelian inheritance mechanisms</strong> (genetic heterogeneity) tend to be <strong>more severe </strong>in <strong>recessive </strong>rather than dominant forms, and recessive conditions are less variable than dominant phenotypes. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Most mattings </strong>involve <strong>persons </strong>who have <strong>mutations at different loci</strong>, hence related persons are more likely to inherit the same mutant gene, consanguinity increases the possibility of homozygous affected offspring.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong><span style=\"font-size:12.0pt\"><strong>Both alleles </strong>are <strong>defective </strong>but do not contain the exact same mutation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong><span style=\"font-size:12.0pt\">They have a <strong>horizontal pattern of affected persons </strong>in the <strong>pedigree</strong>. Males and females are affected with equal frequency and severity.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong><span style=\"font-size:12.0pt\">All <strong>individuals </strong>carry <strong>6 to 12 mutant recessive alleles</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Autosomal recessive </strong>conditions, such as <strong>type IV glycogen storage disease</strong>, are frequently characterized by a <strong>deficiency in enzyme activity</strong>. This is because both copies of the gene in question (one from each parent) must be affected for the disorder to manifest, typically resulting in the absence or malfunctioning of an enzyme or protein.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Harper 31/e, p 820-821</span></strong></span></span></p>",
      "correct_choice_id": 38251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6383,
      "choices": [
        {
          "id": 25501,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I</span></span></span></p>"
        },
        {
          "id": 25502,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type II</span></span></span></p>"
        },
        {
          "id": 25503,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type V</span></span></span></p>"
        },
        {
          "id": 25504,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type VII</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following glycogen storage diseases typically spares the muscles from involvement? </span></span></p>",
      "unique_key": "Q4095556",
      "question_audio": null,
      "question_video": null,
      "map_id": 29990,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Type I</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogen Storage Disease Type I</strong>, also known as<strong> Von Gierke disease,</strong> primarily affects the <strong>liver and kidneys</strong> and is characterized by the <strong>deficiency </strong>of the enzyme<strong> glucose-6-phosphatase.</strong> This enzyme is crucial for the<strong> final steps of gluconeogenesis </strong>and <strong>glycogenolysis</strong>, allowing<strong> glucose </strong>to be released into the<strong> bloodstream.</strong> Due to the <strong>enzyme&#39;s absence </strong>in <strong>muscle tissue</strong>, <strong>GSD Type I</strong> <strong>does not </strong>directly <strong>involve</strong> <strong>muscle pathology.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Type II:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type II, or<strong> Pompe disease</strong>, involves <strong>lysosomal alpha-1,4-glucosidase deficiency</strong> and affects <strong>cardiac and skeletal</strong> <strong>muscles,</strong> leading to <strong>progressive muscle weakness.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Type V:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type V, known as <strong>McArdle disease</strong>, specifically affects<strong> muscle phosphorylase </strong>and is characterized by<strong> muscle</strong> <strong>cramps and exercise intolerance</strong>, indicating <strong>direct muscle involvement.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Type VII:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type VII, or<strong> Tarui disease,</strong> involves <strong>phosphofructokinase deficiency </strong>in muscle cells, leading to <strong>exercise</strong> <strong>intolerance and myopathy,</strong> hence<strong> directly affecting muscles</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Von Gierke disease (Ia) </strong>is due to<strong> Glucose 6 phosphatase deficiency</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features include <strong>glycogen </strong>accumulation in<strong> liver and renal tubule cells</strong>, <strong>hypoglycaemia, lactic acidemia, ketosis</strong> and <strong>hyperlipidemia</strong>. (<strong>No muscle weakness</strong>).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle Glycogen Storage Disorders:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture2.jpg\" style=\"height:241px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Nelson 20/e Defects in the metabolism of Carbohydrates</span></strong></span></span></p>",
      "correct_choice_id": 25501,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}